Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY® Endovascular Robotic System

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. SPY
3. META
4. ABBV
5. FDX
6. IBM
7. MU
8. PFE
9. ACN
10. USO

Go back to Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY® Endovascular Robotic System
(NASDAQ: MBOT) Delayed: 1.82 -0.03 (1.62%)
Previous Close $1.85    52 Week High $ 
Open $1.79    52 Week Low $ 
Day High $1.90    P/E N/A 
Day Low $1.78    EPS $ 
Volume 892,668       

(NASDAQ: MBOT) Delayed: 1.82 -0.03 (1.62%)
Previous Close $1.85    52 Week High $ 
Open $1.79    52 Week Low $ 
Day High $1.90    P/E N/A 
Day Low $1.78    EPS $ 
Volume 892,668